{"version":"1.0","provider_name":"MIT Department of Biology","provider_url":"https:\/\/biology.mit.edu","author_name":"Raleigh McElvery","author_url":"https:\/\/biology.mit.edu\/author\/rmcelvery\/","title":"Drug-resistant cancer cells create own Achilles heel","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"MzLRWsBvxD\"><a href=\"https:\/\/biology.mit.edu\/drug-resistant-cancer-cells-create-own-achilles-heel\/\">Drug-resistant cancer cells create own Achilles heel<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/biology.mit.edu\/drug-resistant-cancer-cells-create-own-achilles-heel\/embed\/#?secret=MzLRWsBvxD\" width=\"600\" height=\"338\" title=\"&#8220;Drug-resistant cancer cells create own Achilles heel&#8221; &#8212; MIT Department of Biology\" data-secret=\"MzLRWsBvxD\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/biology.mit.edu\/wp-content\/uploads\/2019\/05\/Lindquist_Paper.jpg","thumbnail_width":1408,"thumbnail_height":878,"description":"Cambridge, MA &#8212; The cells of most patients\u2019 cancers are resistant to a class of drugs, called proteasome inhibitors, that should kill them. When studied in the lab, these drugs are highly effective, yet hundreds of clinical trials testing proteasome inhibitors have failed. Now scientists may have solved the mystery of these cells\u2019 surprising hardiness. [&hellip;]"}